The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Advances in drug development in myeloma treatment
Mohamad Mohty
• 28 Feb 2022
In this video, Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, highlights the numerous novel drugs that have been approved for the treatment of multiple myeloma, as well as those to come, including antibodies, inhibitors, immunomodulatory drugs (IMiDs) and more. Preliminary findings and applications of these novel agents will be addressed at the 2022 COMy congress in Paris, France.
